Report Detail
Global RNA Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
- RnM3736952 |
- 10 September, 2019 |
- Global |
- 123 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
RNA is a rather versatile technology and offers a number of advantages. RNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes RNA especially attractive for vaccines and gene editing. RNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of RNA has greatly favored the development of in vivo transfection strategies.
RNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of RNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.
Scope of the Report:
The worldwide market for RNA Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the RNA Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
Market Segment by Applications, can be divided into
Infectious Disease
Cancer
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe RNA Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of RNA Vaccines, with price, sales, revenue and global market share of RNA Vaccines in 2017 and 2018.
Chapter 3, the RNA Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the RNA Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, RNA Vaccines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe RNA Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
- 1.1 RNA Vaccines Introduction
- 1.2 Market Analysis by Type
- 1.2.1 Individualized Cancer Treatment MRNA Vaccine
- 1.2.2 Infectious Disease Treatment MRNA Vaccine
- 1.2.3 Infection Prevention MRNA Vaccine
- 1.3 Market Analysis by Applications
- 1.3.1 Infectious Disease
- 1.3.2 Cancer
- 1.3.3 Other
- 1.4 Market Analysis by Regions
- 1.4.1 North America (United States, Canada and Mexico)
- 1.4.1.1 United States Market States and Outlook (2014-2024)
- 1.4.1.2 Canada Market States and Outlook (2014-2024)
- 1.4.1.3 Mexico Market States and Outlook (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy)
- 1.4.2.1 Germany Market States and Outlook (2014-2024)
- 1.4.2.2 France Market States and Outlook (2014-2024)
- 1.4.2.3 UK Market States and Outlook (2014-2024)
- 1.4.2.4 Russia Market States and Outlook (2014-2024)
- 1.4.2.5 Italy Market States and Outlook (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- 1.4.3.1 China Market States and Outlook (2014-2024)
- 1.4.3.2 Japan Market States and Outlook (2014-2024)
- 1.4.3.3 Korea Market States and Outlook (2014-2024)
- 1.4.3.4 India Market States and Outlook (2014-2024)
- 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
- 1.4.4 South America, Middle East and Africa
- 1.4.4.1 Brazil Market States and Outlook (2014-2024)
- 1.4.4.2 Egypt Market States and Outlook (2014-2024)
- 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
- 1.4.4.4 South Africa Market States and Outlook (2014-2024)
- 1.4.4.5 Turkey Market States and Outlook (2014-2024)
- 1.4.1 North America (United States, Canada and Mexico)
- 1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force
2 Manufacturers Profiles
- 2.1 Moderna Therapeutics
- 2.1.1 Business Overview
- 2.1.2 RNA Vaccines Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Moderna Therapeutics RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 CureVac
- 2.2.1 Business Overview
- 2.2.2 RNA Vaccines Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 CureVac RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.3 Translate Bio
- 2.3.1 Business Overview
- 2.3.2 RNA Vaccines Type and Applications
- 2.3.2.1 Product A
- 2.3.2.2 Product B
- 2.3.3 Translate Bio RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.4 BioNTech
- 2.4.1 Business Overview
- 2.4.2 RNA Vaccines Type and Applications
- 2.4.2.1 Product A
- 2.4.2.2 Product B
- 2.4.3 BioNTech RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.5 Sangamo Therapeutics
- 2.5.1 Business Overview
- 2.5.2 RNA Vaccines Type and Applications
- 2.5.2.1 Product A
- 2.5.2.2 Product B
- 2.5.3 Sangamo Therapeutics RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.6 Argos Therapeutics
- 2.6.1 Business Overview
- 2.6.2 RNA Vaccines Type and Applications
- 2.6.2.1 Product A
- 2.6.2.2 Product B
- 2.6.3 Argos Therapeutics RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.7 In-Cell-Art
- 2.7.1 Business Overview
- 2.7.2 RNA Vaccines Type and Applications
- 2.7.2.1 Product A
- 2.7.2.2 Product B
- 2.7.3 In-Cell-Art RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.8 eTheRNA
- 2.8.1 Business Overview
- 2.8.2 RNA Vaccines Type and Applications
- 2.8.2.1 Product A
- 2.8.2.2 Product B
- 2.8.3 eTheRNA RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.9 Ethris
- 2.9.1 Business Overview
- 2.9.2 RNA Vaccines Type and Applications
- 2.9.2.1 Product A
- 2.9.2.2 Product B
- 2.9.3 Ethris RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.10 Tiba Biotechnology
- 2.10.1 Business Overview
- 2.10.2 RNA Vaccines Type and Applications
- 2.10.2.1 Product A
- 2.10.2.2 Product B
- 2.10.3 Tiba Biotechnology RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global RNA Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
- 3.1 Global RNA Vaccines Sales and Market Share by Manufacturer (2017-2018)
- 3.2 Global RNA Vaccines Revenue and Market Share by Manufacturer (2017-2018)
- 3.3 Market Concentration Rate
- 3.3.1 Top 3 RNA Vaccines Manufacturer Market Share in 2018
- 3.3.2 Top 6 RNA Vaccines Manufacturer Market Share in 2018
- 3.4 Market Competition Trend
4 Global RNA Vaccines Market Analysis by Regions
- 4.1 Global RNA Vaccines Sales, Revenue and Market Share by Regions
- 4.1.1 Global RNA Vaccines Sales and Market Share by Regions (2014-2019)
- 4.1.2 Global RNA Vaccines Revenue and Market Share by Regions (2014-2019)
- 4.2 North America RNA Vaccines Sales and Growth Rate (2014-2019)
- 4.3 Europe RNA Vaccines Sales and Growth Rate (2014-2019)
- 4.4 Asia-Pacific RNA Vaccines Sales and Growth Rate (2014-2019)
- 4.5 South America RNA Vaccines Sales and Growth Rate (2014-2019)
- 4.6 Middle East and Africa RNA Vaccines Sales and Growth Rate (2014-2019)
5 North America RNA Vaccines by Country
- 5.1 North America RNA Vaccines Sales, Revenue and Market Share by Country
- 5.1.1 North America RNA Vaccines Sales and Market Share by Country (2014-2019)
- 5.1.2 North America RNA Vaccines Revenue and Market Share by Country (2014-2019)
- 5.2 United States RNA Vaccines Sales and Growth Rate (2014-2019)
- 5.3 Canada RNA Vaccines Sales and Growth Rate (2014-2019)
- 5.4 Mexico RNA Vaccines Sales and Growth Rate (2014-2019)
6 Europe RNA Vaccines by Country
- 6.1 Europe RNA Vaccines Sales, Revenue and Market Share by Country
- 6.1.1 Europe RNA Vaccines Sales and Market Share by Country (2014-2019)
- 6.1.2 Europe RNA Vaccines Revenue and Market Share by Country (2014-2019)
- 6.2 Germany RNA Vaccines Sales and Growth Rate (2014-2019)
- 6.3 UK RNA Vaccines Sales and Growth Rate (2014-2019)
- 6.4 France RNA Vaccines Sales and Growth Rate (2014-2019)
- 6.5 Russia RNA Vaccines Sales and Growth Rate (2014-2019)
- 6.6 Italy RNA Vaccines Sales and Growth Rate (2014-2019)
7 Asia-Pacific RNA Vaccines by Country
- 7.1 Asia-Pacific RNA Vaccines Sales, Revenue and Market Share by Country
- 7.1.1 Asia-Pacific RNA Vaccines Sales and Market Share by Country (2014-2019)
- 7.1.2 Asia-Pacific RNA Vaccines Revenue and Market Share by Country (2014-2019)
- 7.2 China RNA Vaccines Sales and Growth Rate (2014-2019)
- 7.3 Japan RNA Vaccines Sales and Growth Rate (2014-2019)
- 7.4 Korea RNA Vaccines Sales and Growth Rate (2014-2019)
- 7.5 India RNA Vaccines Sales and Growth Rate (2014-2019)
- 7.6 Southeast Asia RNA Vaccines Sales and Growth Rate (2014-2019)
8 South America RNA Vaccines by Country
- 8.1 South America RNA Vaccines Sales, Revenue and Market Share by Country
- 8.1.1 South America RNA Vaccines Sales and Market Share by Country (2014-2019)
- 8.1.2 South America RNA Vaccines Revenue and Market Share by Country (2014-2019)
- 8.2 Brazil RNA Vaccines Sales and Growth Rate (2014-2019)
- 8.3 Argentina RNA Vaccines Sales and Growth Rate (2014-2019)
- 8.4 Colombia RNA Vaccines Sales and Growth Rate (2014-2019)
9 Middle East and Africa RNA Vaccines by Countries
- 9.1 Middle East and Africa RNA Vaccines Sales, Revenue and Market Share by Country
- 9.1.1 Middle East and Africa RNA Vaccines Sales and Market Share by Country (2014-2019)
- 9.1.2 Middle East and Africa RNA Vaccines Revenue and Market Share by Country (2014-2019)
- 9.2 Saudi Arabia RNA Vaccines Sales and Growth Rate (2014-2019)
- 9.3 Turkey RNA Vaccines Sales and Growth Rate (2014-2019)
- 9.4 Egypt RNA Vaccines Sales and Growth Rate (2014-2019)
- 9.5 Nigeria RNA Vaccines Sales and Growth Rate (2014-2019)
- 9.6 South Africa RNA Vaccines Sales and Growth Rate (2014-2019)
10 Global RNA Vaccines Market Segment by Type
- 10.1 Global RNA Vaccines Sales, Revenue and Market Share by Type (2014-2019)
- 10.1.1 Global RNA Vaccines Sales and Market Share by Type (2014-2019)
- 10.1.2 Global RNA Vaccines Revenue and Market Share by Type (2014-2019)
- 10.2 Individualized Cancer Treatment MRNA Vaccine Sales Growth and Price
- 10.2.1 Global Individualized Cancer Treatment MRNA Vaccine Sales Growth (2014-2019)
- 10.2.2 Global Individualized Cancer Treatment MRNA Vaccine Price (2014-2019)
- 10.3 Infectious Disease Treatment MRNA Vaccine Sales Growth and Price
- 10.3.1 Global Infectious Disease Treatment MRNA Vaccine Sales Growth (2014-2019)
- 10.3.2 Global Infectious Disease Treatment MRNA Vaccine Price (2014-2019)
- 10.4 Infection Prevention MRNA Vaccine Sales Growth and Price
- 10.4.1 Global Infection Prevention MRNA Vaccine Sales Growth (2014-2019)
- 10.4.2 Global Infection Prevention MRNA Vaccine Price (2014-2019)
11 Global RNA Vaccines Market Segment by Application
- 11.1 Global RNA Vaccines Sales Market Share by Application (2014-2019)
- 11.2 Infectious Disease Sales Growth (2014-2019)
- 11.3 Cancer Sales Growth (2014-2019)
- 11.4 Other Sales Growth (2014-2019)
12 RNA Vaccines Market Forecast (2019-2024)
- 12.1 Global RNA Vaccines Sales, Revenue and Growth Rate (2019-2024)
- 12.2 RNA Vaccines Market Forecast by Regions (2019-2024)
- 12.2.1 North America RNA Vaccines Market Forecast (2019-2024)
- 12.2.2 Europe RNA Vaccines Market Forecast (2019-2024)
- 12.2.3 Asia-Pacific RNA Vaccines Market Forecast (2019-2024)
- 12.2.4 South America RNA Vaccines Market Forecast (2019-2024)
- 12.2.5 Middle East and Africa RNA Vaccines Market Forecast (2019-2024)
- 12.3 RNA Vaccines Market Forecast by Type (2019-2024)
- 12.3.1 Global RNA Vaccines Sales Forecast by Type (2019-2024)
- 12.3.2 Global RNA Vaccines Market Share Forecast by Type (2019-2024)
- 12.4 RNA Vaccines Market Forecast by Application (2019-2024)
- 12.4.1 Global RNA Vaccines Sales Forecast by Application (2019-2024)
- 12.4.2 Global RNA Vaccines Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
- 13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.1.3 Marketing Channel Future Trend
- 13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
- 15.1 Methodology
Summary:
Get latest Market Research Reports on RNA Vaccines. Industry analysis & Market Report on RNA Vaccines is a syndicated market report, published as Global RNA Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of RNA Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
